Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 215

The DOI matches its Crossref record.

Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry

Quijano, Sandra, López, Antonio, Manuel Sancho, Juan, Panizo, Carlos, Debén, Guillermo, Castilla, Cristina, Antonio García-Vela, José, Salar, Antonio, Alonso-Vence, Natalia, González-Barca, Eva, Peñalver, Francisco Javier, Plaza-Villa, Josefa, Morado, Marta, García-Marco, José, Arias, Jesús, Briones, Javier, Ferrer, Secundino, Capote, Javier, Nicolás, Concepción, Orfao, Alberto · 2009 · Journal of Clinical Oncology

Abstract

Purpose: Here, we evaluate the sensitivity and specificity of a new 11-parameter flow cytometry (FCM) approach versus conventional cytology (CC) for detecting neoplastic cells in stabilized CSF samples from newly diagnosed aggressive B-cell non-Hodgkin's lymphoma (B-NHL) at high risk of CNS relapse, using a prospective, multicentric study design. Patients and Methods: Moreover, we compared the distribution of different subpopulations of CSF leukocytes and the clinico-biologic characteristics of CSF+ versus CSF−, patients, in an attempt to define new algorithms useful for predicting CNS disease. Results: Overall, 27 (22%) of 123 patients showed infiltration by FCM, while CC was positive in only seven patients (6%), with three other cases being suspicious (2%). CC+/FCM+ samples typically had more than 20% neoplastic B cells and/or ≥ one neoplastic B cell/μL, while FCM+/CC− samples showed lower levels (P < .0001) of infiltration. Interestingly, in Burkitt lymphoma, presence of CNS disease by FCM could be predicted with a high specificity when increased serum β2-microglobulin and neurological symptoms coexisted, while peripheral blood involvement was the only independent parameter associated with CNS disease in diffuse large B-cell lymphoma, with low predictive value. Conclusion: FCM significantly improves the sensitivity of CC for the identification of leptomeningeal disease in aggressive B-NHL at higher risk of CNS disease, particularly in paucicellular samples.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2008.17.7089

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 215

Metadata

Authors
Quijano, S., López, A., Manuel Sancho, J., Panizo, C., Debén, G., Castilla, C., Antonio García-Vela, J., Salar, A., Alonso-Vence, N., González-Barca, E., Peñalver, F. J., Plaza-Villa, J., Morado, M., García-Marco, J., Arias, J., Briones, J., Ferrer, S., Capote, J., Nicolás, C., & Orfao, A.
Venue
Journal of Clinical Oncology
Published
2009-03-20
Volume
27
Issue
9
Pages
1462-1469
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2166676098
Cited by
215
References
0
FWCI
10.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry. https://app.cochat.ai/papers/10.1200/jco.2008.17.7089
The paper
Quijano, S., López, A., Manuel Sancho, J., Panizo, C., Debén, G., Castilla, C., Antonio García-Vela, J., Salar, A., Alonso-Vence, N., González-Barca, E., Peñalver, F. J., Plaza-Villa, J., Morado, M., García-Marco, J., Arias, J., Briones, J., Ferrer, S., Capote, J., Nicolás, C., & Orfao, A. (2009). Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2008.17.7089

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.